Arbutus Biopharma (ABUS) Net Income (2009 - 2026)
Arbutus Biopharma recorded quarterly Net Income of $169.7 million in Q1 2026, up 3929.97% quarter-over-quarter from -$4.4 million in Q4 2025, and up 791.83% year-over-year from $19.0 million in Q1 2025.
Arbutus Biopharma's Net Income history runs 18 years deep, the most recent figure standing at $169.7 million for Q1 2026.
- In Q1 2026, Net Income rose 791.83% year-over-year to $169.7 million; the TTM figure through Mar 2026 stood at $160.0 million (up 309.11% YoY), while the FY2025 annual figure was -$34.2 million, up 51.1% from the prior year.
- Net Income came in at $169.7 million for Q1 2026 at Arbutus Biopharma, up from -$4.4 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $169.7 million in Q1 2026 to a low of -$24.5 million in Q1 2025.
- A 5-year average of -$4.5 million and a median of -$17.1 million in 2023 frame the typical range for Net Income.
- Across the five-year window, Net Income sank 37.33% in 2025 and soared 791.83% in 2026, its largest moves.
- Arbutus Biopharma's Net Income stood at -$21.9 million in 2022, then climbed by 11.95% to -$19.3 million in 2023, then soared by 35.28% to -$12.5 million in 2024, then jumped by 64.55% to -$4.4 million in 2025, then surged by 3929.97% to $169.7 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $169.7 million, -$4.4 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Arbutus Biopharma | 883.58 Mn | 883.58 Mn | - | 169.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169.71 Mn |
| Dec 31, 2025 | -4.43 Mn |
| Sep 30, 2025 | -7.73 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | -24.53 Mn |
| Dec 31, 2024 | -12.50 Mn |
| Sep 30, 2024 | -19.72 Mn |
| Jun 30, 2024 | -19.79 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Dec 31, 2023 | -19.31 Mn |
| Sep 30, 2023 | -20.10 Mn |
| Jun 30, 2023 | -17.09 Mn |
| Mar 31, 2023 | -16.34 Mn |
| Dec 31, 2022 | -21.93 Mn |
| Sep 30, 2022 | -17.57 Mn |
| Jun 30, 2022 | -14.19 Mn |
| Mar 31, 2022 | -15.77 Mn |
| Dec 31, 2021 | -21.32 Mn |
| Sep 30, 2021 | -19.16 Mn |
| Jun 30, 2021 | -19.39 Mn |
| Mar 31, 2021 | -16.38 Mn |
| Dec 31, 2020 | -17.04 Mn |
| Sep 30, 2020 | -18.76 Mn |
| Jun 30, 2020 | -14.09 Mn |
| Mar 31, 2020 | -13.86 Mn |
| Dec 31, 2019 | -24.65 Mn |
| Sep 30, 2019 | -82.50 Mn |
| Jun 30, 2019 | -23.32 Mn |
| Mar 31, 2019 | -23.25 Mn |
| Dec 31, 2018 | -18.25 Mn |
| Sep 30, 2018 | -24.47 Mn |
| Jun 30, 2018 | 3.09 Mn |
| Mar 31, 2018 | -17.75 Mn |
| Dec 31, 2017 | -35.93 Mn |
| Sep 30, 2017 | -11.60 Mn |
| Jun 30, 2017 | -18.26 Mn |
| Mar 31, 2017 | -17.97 Mn |
| Dec 31, 2016 | -218.70 Mn |
| Sep 30, 2016 | -19.60 Mn |
| Jun 30, 2016 | -130.00 Mn |
| Mar 31, 2016 | -19.73 Mn |
| Dec 31, 2015 | -6.86 Mn |
| Sep 30, 2015 | -28.98 Mn |
| Jun 30, 2015 | -14.89 Mn |
| Mar 31, 2015 | -17.80 Mn |
| Dec 31, 2014 | -10.60 Mn |
| Sep 30, 2014 | -6.54 Mn |
| Jun 30, 2014 | -9.17 Mn |
| Mar 31, 2014 | -5.81 Mn |
| Dec 31, 2013 | -2.31 Mn |
| Sep 30, 2013 | -3.49 Mn |
| Jun 30, 2013 | -2.95 Mn |
| Mar 31, 2013 | -2.91 Mn |
| Dec 31, 2012 | -5.93 Mn |
| Sep 30, 2012 | -1.75 Mn |
| Jun 30, 2012 | -2.53 Mn |
| Mar 31, 2012 | -2.61 Mn |
| Dec 31, 2011 | -2.07 Mn |
| Sep 30, 2011 | -1.70 Mn |
| Jun 30, 2011 | -3.71 Mn |
| Mar 31, 2011 | -3.09 Mn |
| Dec 31, 2010 | -1.84 Mn |
| Sep 30, 2010 | -2.36 Mn |
| Jun 30, 2010 | -3.78 Mn |
| Mar 31, 2010 | -4.04 Mn |
| Dec 31, 2009 | -1.35 Mn |
| Sep 30, 2009 | -2.34 Mn |